We propose a general solution to the problem of using antibodies originating in the same species for double immunohistochemical labeling. It relies on the use of a two-step protocol in which a secondary polyclonal monovalent F(ab) antibody present in the fmt step blodrs access in the second of the secondary antibody to the primary antibody, which is continuously present fiom the fmt step. The monovalence of the F(ab) fragment eliminates the possibility of its linking the primary antibody from the second step. We designed Nakane PK Simultaneous localization of multiple tissue antigens using the peroxidase-labeled antibody method a study on the pituitary glands of the rat. J Histochem Cycochem 16:157, 1968 Pitzolo G, Chilosi M: Double immunostaining of lymph node sections by monoclonal antibodies using phycoerythrin labeling and haptenated reagents. Am J Clin Pathol 82:44. 1984 F(ab) DOUBLE-IMMUNOLABELING METHOD 8. Shin M, Hockfield S: Molecular identification of the lugaro cell in the cat cerebellar cortex. J Comp Neurol 301575, 1990
Introduction
presented in this journal the first successful attempt involving the simultaneous immunodeteaion of three hormonal antigens present on anterior pituitary by use of peroxidase, the sole available enzyme tracer at that time. However, the realization of reliable double immunolabeling when the primary antibodies originate in the same species remained a recurrent problem because most immunohistochemists are not in a position to couple primary antibodies to a tracer as Nakane did; moreover, they prefer to keep open the possibility of altemate detection systems. Two types of interference must be prevented: first, capture of the primary antibody in the second step by residual free binding sites of the secondary antibody from the first step; second, linkage of the secondary antibody in the second step to the first antibody from the first step ( Figure 1A) . Various solutions, more or less efficient but with limited scope, have been imagined, most of them exploiting &type differences between two monoclonal antibodies (2, 8, 10) . two efficiency tests to explore the l i m i t s of the method by the very sensitive chemiluminescent system applied to sections of human pituitary tissue. They confiied both the validity of the method and the necessity of adapting working conditions to obtain a complete lack of interference. (] KEY WORDS: Immunohistochemistry; Double labeling; Same species; Chemiluminescence.
Histochun cytochem 42:4?3-437,1994)
The introduction of biotinylation kits, generally available, made possible systems in which one of the steps is, as in Nakane's method, reduced to the use of a single biotinylated antibody followed by tracer-coupled streptavidin (1, 5, 7, 9, 11) .
We propose a method based on the use of a secondary F(ab) polyclonal antibody, either coupled or not, during the first step. Its role is to block all the epitopes of the primary antibody, thus preventing interference with the secondary antibody of the second step (Type I1 interference). The monovalent feature of the F(ab) fragment renders impossible the capture of the primary antibody of the second step (Type I interference). This system requires no chemical alteration of primary antibodies and can be adapted to any pair of primary antibodies originating from the same species, thus offering a very general approach to the problem. We have submitted this procedure to the highly sensitive chemiluminescence detection method (4) to ensure actual prevention of both interferences. It appears that the method is effective provided that it is adapted to the selection of antibodies one chooses.
Materials and Methods
Tissue samples were normal pituitary obtained either at autopsy or as surgical specimens, the latter from areas not involved with pituitary adenoma. 40 gllitcr picric acid in 10% formalin, 1.5% acetic acid in distilled water) and pdin-processed. Five-Bm sections that were close to one another were dcwwcd and rehydrated. one of them being stained with hematoxylin-eosin-dron (HES) to assist morphological identification ( Figure 1G ). Endogenous peroxidases were inhibited by 0.3% H202 in 0.1 M PBS, pH 7.4, for 10 min, followed by washing in the same buffer three times for 3 min. Nonspecific linkage was blocked in 20% normal donkey serum in 0.1 M PBS, pH 7.4. for 30 min before each antibody incubation. Various samc-species primary antibodies were used, alternating them in the fmt or the second step. We describe the double labeling shown in Figure 1K .
First
Step. Rabbit polyclonal anti-human growth hormone (hGH) antibody (1:3000; a gift from Pr. I. Bachelot, CHRU Grenoble, France) was incubated for 2 hr at room temperature (RT), followed by a polydonal affinity-purified peroxidase-conjugated goat F(ab) anti-rabbit IgG (H+L) (0.16 mg/ml) (Cappel Organon T e k n k Turnhout, Belgium, 556881 34120081) for 3 hr at RT. The chromogenic substrate of peroxidase was a solution of 0.05% 3,3'diuninobCnZidine teuahydrochloride (DAB)/O.O5% H202/10 mM imidazole in 0.05 M Eis buffer, pH 7.6.
b n d
Step. Rabbit polyclonal anti-human adrenocorticotrophic hormone (amino acids 117-391) (h17-39Am) antibody (1:8000, a gift from Pr. P. M. Dubois, INRA Nouzilly, France) was incubated for 2 hr at RT, followed by a polydonal affinity-purified alkaline phosphatase-conjugated donkey F(ab')z anti-rabbit IgG (H+L) (6 pglml) Uackson; West Grove, PA, 711/056/132) for 1 hr at RT. The chromogenic substrate of alkaline phosphatase was a solution of 100% diazotitited 4'-amino 2',5'-dicthoxybenzanilide zinc chloride (Fast Blue) salt (FB)/100% naphthol AS-MX phosphate/25% levamisole HCl/2% N,N-dicmthylfo"ide in 0.05 M 2-amino 2-methy1, 1,3-propanediol b&r, pH 8.7. The slide were mounted in Aquamount (BDH).
Controls.
Interference control sections were prepared by omitting the primary antibody in the second immunolabeling step, as we usually do when using primary antibodies from different species. The absence of FB staining proved that the second-sequence anti-rabbit antibody did not fmd free cpitopcs on the fim-step rabbit primary antibody (Type 11 interference).
To identify the conditions in which the use of an F(ab) fragment as secondary antibody in the first step would preclude both types of interference, two tests were performed ( Figure 1B ). Test I. The purpose of this test was to prove that the monovalence of the F(ab) fragment prevents Type I interference, is., second-step primary rabbit antibody being trapped by free binding sites of the anti-rabbit antibody from the first step. Sections were treated with the rabbit anti-hGH Ab for 2 hr at RT, followed by an unconjugated polydonal affhity-purified goat F(ab) anti-rabbit IgG (H+L) (Cappel Organon Teknika, 28994 04120081) at concentrations ranging from 0.04 to 1.2 mg/ml for 1 hr, 3 hr at RT, or overnight at 4'C. Sections were then incubated for 3 hr at RT with a rabbit peroxidase-anti-peroxidase complex (0.3 mg/ml) (Jackson, 323/007/024). which serves as the second-step primary antibody. The cxpected result being negative, a positive control was provided by replacing the F(ab) by a divalent donkey anti-rabbit F(ab')z fragment (5.6 wg/ml) (Jackson, 711/006/132). k t II. The purpose of Test I1 was to prove that F(ab) saturation of the epitopes of the rabbit immunoglobulins prcvcnts Type I1 interference, i.e., second-step anti-rabbit antibody binding to the rabbit antibody of the first step. We explored the limiting conditions of concentration and incubation time of the F(ab) (but also of the other antibodies) for which the method is valid. For this purpose, closc sections were incubated with the rabbit anti-hGH antibody for 30 min or 2 hr at RT, followed by an incubation either for 1 hr. 3 hr at RT or overnight at 4'C, with the blocking unconjugated goat anti-rabbit F(ab) at concentrations ranging from 0.04 to 1.2 mg/ml. Then a pcroxidase-coupled donkey anti-rabbit F(ab' )z fragment (3.2 wg/ml) (Jackson 711/036/132), serving as the second-step secondary antibody was applied for 30 min or 3 hr. The expected result being negative, a positive control was induded by omitting the F(ab) ( Figure 1H ).
Chemiluminescence Control. To submit the negativity of both tests to a very sensitive means of detection, we performed a luminescence detcction of the peroxidase with luminol before the DAB reaction, as previously described (4). Briefly, the chemiluminescent substrate of peroxidase was a freshly prepared solution (v/v) of ECL reagents (Amersham; Amersham, UK). The luminescence signal was picked up by a photon-collecting system situated in a light-tight endosure. This equipment consisted of an Olympus BH2 microscope equipped with a photon intensifier connected to a CCD camera (IHCD 2400-47; Hamamatsu, Hamamatsu City, Japan) possessing a sensitivity spectrum adapted to the light emitted by the luminescence reaction ( X , 430 nm). The chemiluminescence signal was visualized on a color video monitor (Sony; Tokyo, Japan). An ARGUS 10 (Hamamatsu) image processor allowed processing and the analysis of the signal.
Tissue structures and cells were first located in transmitted light on the screen to assist in morphological identification ( Figure IC) . The integration ofthe luminescence signal was obtained by means of a photon-counting function. Photon accumulation, lasting 10 min, ensured the formation of an image on the video screen. The images were obtained by photographing the screen ( Figures 1C-1F ).
Normal immunoglobulins of the same species. type and concentration as the primary antibody (rabbit gamma globulin; Jackson 011-000-002) used instead of the primary antibody served as negative control for chromogenic labeling and provided the background threshold level for chemiluminescence detection. 
Results
The F(ab) method has been demonstrated by a double-labeling protocol designed to permit the use of two rabbit primary antibodies against hGH and h17-39ACTH on human pituitary tissues ( Figure 1K) ; this method prevented the two types of interference when the primary antibodies originated in the same species. The monovalent feature of the F(ab) fragment prevented Type I interference, and saturation of the epitopes of the first-step primary antibody by the secondary polyclonal F(ab) precluded Type I1 interference.
The tests designed to explore these two interference types show that Type I interference is hindered by the F(ab) monovalence, whatever the F(ab) concentrations in the range used, for 1 hr, 3 hr, and overnight incubations, as detected by chemiluminescence and chromogenic techniques (not shown). The saturation of the rabbit immunoglobulin epitopes by the anti-rabbit F(ab) (6. interference type 11) was not complete in all the working conditions explored ( Figures 1E and 11) . Thus, a 1-hr F(ab) incubation at RT proved inefficient whatever the Fab concentration, for a 2-hr incubation of the primary rabbit anti-hGH antibody and a 3-hr incubation of the peroxidase-coupled anti-rabbit antibody. For F(ab) incubations of 3 hr at RT or overnight at 4"C, negativity was obtained but only within limited ranges of F(ab) concentrations, wider for DAB (0.06-0.6 mglml) (Figure lJ) and narrower for chemiluminescence (0.08-0.48 mglml) ( Figure IF) . The blocking effect of the F(ab) was also obtained for the entire range of tested concentrations (0.04-1.2 mglml) whatever the duration of the saturation (1 hr to overnight) when reducing to 30 min the incubations of both the hGH-and peroxidase-conjugated anti-rabbit antibodies. Positive controls validated both tests, giving similar results, as illustrated for Test I1 by chemiluminescence ( Figure 1D ) and DAB ( Figure 1H ). However, the hGH immunolabeling was somewhat faint, although acceptable, for a 30-min incubation of the antibody.
Discussion
In the present study we propose a general and simple solution to the problem of double labeling with primary antisera raised in the same species. The fact that a great number of primary antibodies originate in a small number of species, mainly rabbit and mouse, has limited multiple labelings. Our method relies on the use of a secondary polyclonal monovalent F(ab) antibody in the first step to block the epitopes on the primary antibody, thus preventing access of the secondary antibody in the second step to the primary antibody from the first step. The monovalence of the F(ab) fragment prevents it from capturing the primary antibody from the second step. The anti-interference effect of the Fab was investigated through two tests which showed that it prevents indeed both interference types. The previous methods make use, as a rule, of a firststep antibody conjugated directly or through biotinylation (1, 5, 6, 7, 9, 11) . The F(ab) method avoids any chemical alteration of the primary antibodies. Moreover, it allows complete liberty in the choice of detection systems for both steps. The small size of the F(ab) fragment also improves cell penetration. Lewis Carl et al. (3) proposed the use of the F(ab) fragment in another configuration requiring a four-layer antibody combination in the first step. This approach is therefore less simple than ours; its advantage is to offer a solution when one has only an uncoupled F(ab) and no coupled antibody specific for the species in which the F(ab) originates.
However, the successful use of our technique requires at least two prerequisites. First, the F(ab) fragments must originate in a polyclonal antibody, to achieve complete blockage of the epitopes on the primary immunoglobulins. Second, working conditions, i.e., F(ab) and other antibody concentrations and incubation times, must be carefully adapted to the specific antibody assembly of interest, and the effective lack of interference must be verified. In this regard, the highly sensitive chemiluminescence technique (4) proved particularly efficient in showing that both too low and too high F(ab) concentrations did not provide complete saturation, the latter probably due to steric hindrance. The DAB staining was either weak or undetectable at limit working conditions (compare Figures  1E and 1J ).
